Omega Therapeutics News - OMGA

Company Name	Stock Ticker Symbol	Market	Type
Omega Therapeutics Inc	OMGA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.14	-5.96%	2.21	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
2.35	2.26	2.40	2.27	2.35

more quote information »

Recent News

Date	Time	Source	Heading
4/23/2024	07:00	GLOBE	Omega Therapeutics to Present New Preclinical Data on..
4/09/2024	07:00	GLOBE	Omega Therapeutics Presents New Preclinical Data at AACR..
3/28/2024	09:15	GLOBE	Omega Therapeutics Reports Fourth Quarter and Full Year 2023..
3/06/2024	07:00	GLOBE	Omega Therapeutics Announces Two Poster Presentations at the..
2/09/2024	17:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	16:00	EDGAR2	Form 8-K - Current report
1/02/2024	16:05	GLOBE	Omega Therapeutics to Present at the 42nd Annual J.P. Morgan..
12/11/2023	16:00	EDGAR2	Form 8-K - Current report
12/04/2023	16:00	GLOBE	Omega Therapeutics to Participate in the H.C. Wainwright 4th..
11/27/2023	19:01	PRNUS	Flagship Pioneering Marks Official Opening of UK Hub with..
11/21/2023	06:00	PRNUS	Flagship Pioneering Unveils Quotient Therapeutics to Create..
11/20/2023	16:00	GLOBE	Omega Therapeutics to Participate in the Piper Sandler 35th..
11/13/2023	07:00	GLOBE	Omega Therapeutics Showcases Bidirectional and Multiplexed..
11/09/2023	07:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	07:03	EDGAR2	Form 8-K - Current report
11/09/2023	07:00	GLOBE	Omega Therapeutics Reports Third Quarter 2023 Financial..
11/07/2023	16:00	GLOBE	Omega Therapeutics to Participate in The Jefferies London..
10/31/2023	07:00	GLOBE	Omega Therapeutics Presents New Preclinical Data..
10/16/2023	07:00	GLOBE	Omega Therapeutics Presents New Preclinical Data Supporting..
10/11/2023	16:00	GLOBE	Omega Therapeutics Announces Two Poster Presentations on..
10/04/2023	16:00	GLOBE	Omega Therapeutics to Present New Preclinical Data on..
9/26/2023	17:29	EDGAR2	Form 8-K - Current report
9/26/2023	07:00	GLOBE	Omega Therapeutics Announces Promising Preliminary Clinical..
9/25/2023	16:00	GLOBE	Omega Therapeutics to Host Conference Call to Discuss..
9/22/2023	17:10	EDGAR2	Form 8-K - Current report
9/21/2023	16:00	GLOBE	Omega Therapeutics to Participate in Two Upcoming Investor..
9/11/2023	06:30	PRNUS	Flagship Pioneering Announces Appointment of Amanda Kay as..
8/29/2023	16:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/29/2023	16:30	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/29/2023	07:03	EDGAR2	Form 8-K - Current report
8/29/2023	07:00	GLOBE	Omega Therapeutics Announces Updates to its Board of..
8/03/2023	17:13	EDGAR2	Form 8-K - Current report
8/03/2023	17:11	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/03/2023	16:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	16:00	GLOBE	Omega Therapeutics Reports Second Quarter 2023 Financial..
7/13/2023	16:00	EDGAR2	Form 8-K - Current report
7/12/2023	16:01	EDGAR2	Form 8-K - Current report
7/12/2023	07:00	GLOBE	Omega Therapeutics Appoints Chris Schade to its Board of..
6/01/2023	07:00	GLOBE	Omega Therapeutics to Participate in Two Upcoming Investor..
5/31/2023	08:30	GLOBE	Ashvattha Therapeutics Expands Leadership Team with..
5/31/2023	07:00	GLOBE	Omega Therapeutics Presents New Preclinical Data..
5/16/2023	06:00	PRNUS	Flagship Pioneering Launches Metaphore Biotechnologies to..
5/04/2023	07:00	GLOBE	Omega Therapeutics Reports First Quarter 2023 Financial..